The Role of Type 1 Conventional Dendritic Cells in Cancer Immunity.

Böttcher JP, Reis e Sousa C. · 2018

Read The Role of Type 1 Conventional Dendritic Cells in Cancer Immunity. by Böttcher JP, Reis e Sousa C. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6207145.txt.

Description

Böttcher and Reis e Sousa review a rare immune cell type and its role in cancer. Their review appeared in Trends in Cancer. The cells are type 1 conventional dendritic cells, called cDC1s. These cells pick up material from tumours. They then start fresh T cell responses against the cancer. Recent work links them to better survival in human patients.

Inside tumours, cDC1s draw in T cells and release signals that help them work. They also present tumour material to killer T cells on site. In mouse models, tumours fail to be rejected without these cells. T cell therapies also work less well. The authors argue that raising cDC1 numbers in tumours could help more patients respond to immune therapy.

Catalog record

CREATORBöttcher JP, Reis e Sousa C.
YEAR2018
COLLECTIONPAPERS
FORMATTXT
FILE SIZE38 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6207145

Browse the full library · About the Tower of Babel